BULLFROG AI HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number
BULLFROG AI HOLDINGS, INC. (BFRG) had Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number of 668.89 thousand shares as of 2025-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber · last filed 2026-03-19
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 668.89K shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 668.89K shares.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 663.89K shares.
- 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 663.89K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number |
|---|---|
| 2025-12-31 | 668.89K shares 10-K · filed 2026-03-19 |
| 2025-09-30 | 668.89K shares 10-Q · filed 2025-11-14 |
| 2025-06-30 | 663.89K shares 10-Q · filed 2025-08-13 |
| 2025-03-31 | 663.89K shares 10-Q · filed 2025-05-13 |
| 2024-12-31 | 663.89K shares 10-K · filed 2026-03-19 |
| 2024-09-30 | 663.89K shares 10-Q · filed 2025-11-14 |
| 2024-06-30 | 663.89K shares 10-Q · filed 2025-08-13 |
| 2024-03-31 | 663.89K shares 10-Q · filed 2025-05-13 |
| 2023-12-31 | 678.18K shares 10-K · filed 2026-03-19 |
| 2022-12-31 | 678.18K shares 10-K · filed 2025-03-14 |
| 2021-12-31 | 885.37K shares 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B |